SOPH: CLO Van Well Sells 6,168 Shares

What Happened
Van Well Daan, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold 6,168 shares on September 11, 2026 in open-market transactions. The weighted average sale price was $7.63 per share, for total proceeds of $47,089. The filing indicates the sales were executed under a pre-established Rule 10b5-1(c) trading plan.

Key Details

• Transaction date: 2026-09-11 (reported on Form 4 filed 2026-09-14) — filing appears timely.
• Transaction type/code: Sale (S), open-market.
• Shares sold: 6,168; weighted average price: $7.63; total proceeds: $47,089.
• Price range: shares sold at prices between $7.55 and $7.85 (weighted average reported; breakdown by price available on request per footnote).
• Shares owned after transaction: not specified in the provided filing.
• Notable footnotes: F1 — sale made pursuant to a duly adopted Rule 10b5-1(c) trading plan; F2 — weighted average price reported, range $7.55–$7.85 with per-price breakdown available upon written request.

Context
A sale under a 10b5-1 plan is a pre-arranged trade and is generally considered routine (less informative about current management sentiment than an ad-hoc sale or a purchase). No options were exercised and there are no indications of gifts or tax-withholding in this filing.